Ablation of Peripheral, Genicular and Other Nerves and Neuromas
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage and prior authorization expectations for radiofrequency ablation and cryoneurolysis of peripheral nerves (including genicular nerves and peripheral neuromas) for Blue Cross Blue Shield - Rhode Island members, affecting Medicare Advantage and commercial product lines as specified.
Coverage Criteria and Indications
Peripheral Nerve Ablation (CPT 64640) - medical necessity
Peripheral nerve or branch ablation (CPT 64640) may be considered medically necessary when the payer's online clinical criteria are met.
See Prior Authorization of Services, Treatments or Procedures policy for the source of clinical criteria
Genicular and other peripheral nerves - clinical criteria
No in-document, method-specific medical necessity criteria are provided for genicular nerve (CPT 64624) or other peripheral nerves/neuromas (CPT 64632, 0440T–0442T) in this policy segment.
Providers must consult the Prior Authorization policy and online tool for clinical criteria and authorization requirements
Cryoablation device coverage
HCPCS device codes C9808 and C9809 are considered in the context of the associated procedure's medical necessity and Medicare device qualification.
For Medicare Advantage, device codes may be considered medically necessary when the procedure and any Medicare device qualification requirements are met; for Commercial Products device use is not medically necessary as stated in policy
Coverage determinations by indication and product
Coverage determinations vary by indication and product (Medicare Advantage vs Commercial). The following statements summarize those determinations.
Refer to Prior Authorization of Services, Treatments or Procedures policy for the clinical criteria source
Evidence judged insufficient to determine improvement in net health outcome
Evidence insufficient to determine improvement in net health outcome
Evidence insufficient to determine improvement in net health outcome
Refer to Related Policies section
Knee osteoarthritis
Evidence summary and coverage rationale for knee osteoarthritis indications.
Adequately powered, blinded trials with ≥12-month follow-up are needed to determine long-term benefits
Headache indications
Sham-controlled trials recommended
Morton neuroma
Conservative measures (shoe modifications, orthotics, steroid injections) are typical initial management; document prior conservative treatments when applicable
Document prior conservative treatments when applicable
Document prior conservative treatments when applicable
Plantar fasciitis
Other peripheral neuromas
Minimally invasive ablation procedures for other peripheral neuromas are not covered for Medicare Advantage Plans and not medically necessary for Commercial Products
The document provides no in‑text medical necessity criteria for genicular nerve ablation (CPT 64624) or for other peripheral nerves/neuromas (CPT 64632, 0440T–0442T); these sections are labeled Not applicable in this segment and direct reviewers to external clinical criteria or other policy sections for specific authorization requirements.
For genicular nerve ablation, the coding table clarifies that CPT 64624 is covered for Medicare Advantage Plans but is explicitly deemed not medically necessary for Commercial Products due to insufficient evidence of net health outcome improvement; the body text likewise notes no in‑document criteria are provided here.
For other peripheral neuromas and distal peripheral nerve ablations (CPT 64632, 0440T, 0441T, 0442T), the policy states these codes/techniques are not covered for Medicare Advantage Plans and not medically necessary for Commercial Products, and that no internal clinical-criteria node is specified in this document segment.
Device-specific cryoneurolysis coverage is conditional: HCPCS device codes C9808 and C9809 may be considered medically necessary for Medicare Advantage Plans only when the associated procedure is determined to be medically necessary and when Medical Necessity policy criteria are met; these device codes are not medically necessary for Commercial Products.
The policy makes a clear distinction by indication and product: cryoneurolysis for knee osteoarthritis or total knee arthroplasty is not covered for Medicare Advantage Plans and not medically necessary for Commercial Products, and minimally invasive ablation procedures (including intralesional alcohol injection, RFA, and cryoablation) for Morton and other peripheral neuromas are likewise not covered for Medicare Advantage and not medically necessary for Commercial Products.
Where CPT 64640 is used to represent peripheral nerve ablation, the policy requires medical necessity review to determine the specific ablation method (e.g., radiofrequency versus cryoneurolysis) and directs providers to the payer's online authorization/clinical criteria tool for method‑specific criteria and prior authorization guidance.
The coding section lists specific CPT/HCPCS codes that are designated as not covered or not medically necessary for specified products: CPT 64632, and CPT T‑codes 0440T, 0441T, and 0442T are not covered for Medicare Advantage Plans and not medically necessary for Commercial Products.
The policy also lists CPT 64624 (genicular nerve branches) as covered for Medicare Advantage Plans but not medically necessary for Commercial Products, and explicitly ties device HCPCS codes C9808 and C9809 to Medicare Advantage conditional coverage while designating them not medically necessary for Commercial Products.
Providers should note that use of any code listed as not covered or not medically necessary for the applicable product may lead to claim denial or noncoverage per the policy coding table.
Certain sections (Genicular Nerve CPT 64624 and Other Nerves/Neuromas CPT 64632, 0440T–0442T) are presented in this document segment as Not applicable, meaning no explicit in‑document 'not medically necessary' rationale or internal clinical criteria are provided here; instead, the policy refers readers to external clinical criteria tools and related policies for authorization decisions.
Although these sections lack an internal medical‑necessity node in this segment, the coding table and other policy passages do specify product‑level coverage stances (e.g., Medicare Advantage versus Commercial) and therefore operationally function as coverage determinations even where in‑document criteria text is absent.
Providers should therefore follow the payer's online authorization/clinical criteria tool and the Prior Authorization policy for determinations rather than relying on an in‑text criteria checklist within these sections.
The policy explicitly identifies multiple indications and procedures as not covered or not medically necessary: cryoneurolysis or radiofrequency ablation for knee osteoarthritis/total knee arthroplasty and for occipital neuralgia/cervicogenic headache are not covered for Medicare Advantage Plans and not medically necessary for Commercial Products.
Minimally invasive ablation procedures for Morton neuroma and other peripheral neuromas—including intralesional alcohol injection, radiofrequency ablation, and cryoablation—are likewise stated to be not covered for Medicare Advantage Plans and not medically necessary for Commercial Products because the evidence is insufficient to demonstrate an improvement in net health outcome.
The policy also states that nerve cryoablation probe and cryoablation needle devices are not medically necessary for Commercial Products due to insufficient evidence, while they may be considered for Medicare Advantage when device and procedure criteria are met.
For Commercial Products several CPT and HCPCS descriptors and device usages are explicitly designated not medically necessary; examples in the coding section include CPT codes 64632, 0440T, 0441T, and 0442T and device descriptors for HCPCS C9808 and C9809.
The coding table further clarifies that device HCPCS codes C9808 and C9809 may be considered medically necessary for Medicare Advantage Plans only when the associated procedure is medically necessary and the Medical Necessity policy criteria are met, but these same device codes are not medically necessary for Commercial Products.
Providers should ensure prior authorization is obtained where required and verify product‑level coverage before using codes or devices listed as not medically necessary for Commercial Products to avoid claim denials or member financial liability.
Procedure and Device Coding
| 64640 | Peripheral nerve CPT code for ablation (as referenced) |
| 64624 | Genicular nerve CPT code for ablation (as referenced) |
| 64640 | Peripheral nerve CPT code (ablation) — used to represent ablation of peripheral nerve |
| 64624 | Genicular nerve ablation CPT code |
| 64640 | Destruction by neurolytic agent; other peripheral nerve or branch |
| 64624 | Destruction by neurolytic agent, genicular nerve branches including imaging guidance, when performed |
| 64632 | Destruction by neurolytic agent; plantar common digital nerve |
| 0440T | Ablation, percutaneous, cryoablation, includes imaging guidance; upper extremity distal/peripheral nerve |
| 0441T | Ablation, percutaneous, cryoablation, includes imaging guidance; lower extremity distal/peripheral nerve |
| 0442T | Ablation, percutaneous, cryoablation, includes imaging guidance; nerve plexus or other truncal nerve (eg, brachial plexus, pudendal nerve) |
| C9808 | Nerve cryoablation probe (e.g., cryoICE, cryoSPHERE, cryoSPHERE MAX, cryo2), including probe and all disposable system components, nonopioid medical device (must be a qualifying Medicare nonopioid medical device for postsurgical pain relief in accordance with Section 4135 of the CAA, 2023) |
| C9809 | Cryoablation needle (e.g., iovera system), including needle/tip and all disposable system components, nonopioid medical device (must be a qualifying Medicare nonopioid medical device for postsurgical pain relief in accordance with Section 4135 of the CAA, 2023) |
Provider Actions, Prior Authorization & Documentation
Include ablation method in prior authorization
Prior authorization is required for Medicare Advantage Plans and recommended for Commercial Products; when submitting requests for CPT 64640 include documentation specifying the method of ablation (e.g., radiofrequency vs cryoneurolysis) for medical necessity review.
- Include procedure method when reporting CPT 64640
Verify benefits and authorization before scheduling
Verify member-specific benefits, eligibility, and whether prior authorization is required by calling the provider call center or checking the member’s benefit documents before scheduling the procedure.
- Benefits and eligibility determined by the member's subscriber agreement or employer agreement
- For member-specific benefits, call the provider call center
Meet online clinical criteria for CPT 64640
Coverage for peripheral nerve or branch ablation (CPT 64640) is contingent on meeting the clinical criteria in the payer's online authorization tool; providers must use that tool for the appropriate clinical criteria source.
- Follow the Prior Authorization of Services, Treatments or Procedures policy for clinical criteria
Link device codes C9808/C9809 to procedure medical necessity
Document that the associated procedure is medically necessary when submitting requests involving cryoablation device codes C9808 or C9809; device coverage is conditional on procedure medical necessity and meeting the Medical Necessity policy criteria.
Document device qualification and associated procedure necessity
When submitting prior authorization or claims for procedures that may use cryoablation devices, include device HCPCS codes (C9808, C9809) only if the procedure is determined medically necessary and the device meets Medicare device qualification where applicable.
Ensure online authorization tool criteria are satisfied
Medical criteria from the online authorization tool must be met for certain codes to be considered medically necessary for Medicare Advantage and Commercial Products; use the online tool during prior authorization submissions.
- Codes listed as 'may be considered medically necessary' require online criteria be met
Verify benefits and document authorization outcomes
For member-specific coverage determinations and to confirm whether a service is a covered benefit, contact the provider call center; benefits and eligibility supersede this policy and are defined by the member's subscriber agreement or employer agreement.
- Do not assume coverage—verify contract-specific benefits before proceeding
- Provider call center for member-specific questions
Risk of denial for missing prior authorization
Failure to obtain required prior authorization for Medicare Advantage Plans (required) or to use the online tool as recommended for participating providers may result in claim denial or prepayment review.
- Medicare Advantage: prior authorization required
- Commercial: recommended via online tool for participating providers
Denial triggers for noncovered indications
Procedures and device uses explicitly listed as not covered or not medically necessary (e.g., cryoneurolysis for knee osteoarthritis or total knee arthroplasty; RFA or cryoneurolysis for occipital neuralgia/cervicogenic headache; minimally invasive ablation for Morton and other peripheral neuromas) will trigger denial when submitted.
- Cryoneurolysis for knee OA/TKA: not covered (Medicare Advantage) / not medically necessary (Commercial)
- RFA or cryoneurolysis for occipital neuralgia/cervicogenic headache: not covered / not medically necessary
- Minimally invasive ablation for Morton/other peripheral neuromas: not covered / not medically necessary
Avoid submitting disallowed codes to prevent denial
Use of codes listed as 'not covered' or 'not medically necessary' for the product (for example CPT 64632, 0440T–0442T, and listed device descriptors for Commercial Products) will result in denial or noncoverage.
Member charge and denial risk for non-covered services
If a service is determined not medically necessary or is a non-covered benefit, do not charge the member unless they were informed and agreed in writing in advance; verify prior authorization status to avoid unexpected member liability.
- Members cannot be charged for non-covered/not medically necessary services unless informed and signed consent obtained in advance
- Verify authorization and member benefit status to prevent member liability
Conservative Care and Prior Treatments
Document prior conservative treatments when applicable (implied clinical context).
When applicable, document prior conservative treatments as part of the clinical record before proceeding to minimally invasive ablation procedures.
The policy describes these conservative measures as typical initial management but does not specify a required duration; document treatments and responses in the record.
(conservative treatment placeholder)
Providers should document conservative care attempts and outcomes when included in a prior authorization or medical necessity review.
Conservative care described as initial management without explicit duration requirements
Conservative care is described as initial management but no explicit coverage-duration requirements are provided in this section.
Document prior conservative treatments when applicable; refer to the payer's online clinical criteria for any specific prior-therapy requirements.
Frequency and Re-treatment Limits
Imaging and Procedural Guidance
Device coverage (C9808/C9809) tied to procedure medical necessity; imaging not specified
HCPCS device codes C9808 and C9809 may be considered medically necessary only when the associated procedure is determined medically necessary; imaging requirements are not specified for device billing in this segment.
- No imaging requirement for device code coverage is specified in the policy text.
Imaging documentation — verify per code and authorization tool
Policy text does not specify additional imaging documentation requirements for authorization beyond those implied by CPT code descriptors; verify coding guidance per procedure.
- Refer to CPT descriptors and the online authorization tool for any imaging guidance expectations.
Expect imaging guidance documentation for procedures where coding includes imaging
Imaging guidance (ultrasound or fluoroscopy) may be included or expected depending on the procedure coding; use of ultrasound during intralesional alcohol injections has been shown to increase accuracy.
- Some CPT/HCPCS descriptors include imaging guidance; include imaging documentation when applicable.
Background and Evidence Summary
Radiofrequency ablation (RFA) and cryoneurolysis are minimally invasive treatments aimed at interrupting peripheral nerve signaling to reduce pain. RFA uses a needle electrode and high‑frequency electrical current to thermally coagulate target nerve tissue, while cryo neurolysis applies very cold temperatures (approximately −20° to −100°C) to induce Wallerian degeneration with subsequent nerve regeneration over months. The policy evaluates these modalities for peripheral sites (including genicular nerves and peripheral neuromas) and links device code coverage to the medical necessity of the associated procedure.
Definitions
Not Covered / Not Medically Necessary
Cryoneurolysis for knee osteoarthritis or total knee arthroplasty is specifically stated as not covered for Medicare Advantage Plans and not medically necessary for Commercial Products. The policy further clarifies that device codes C9808 and C9809 are considered medically necessary for Medicare Advantage only when the associated procedure is medically necessary and Medical Necessity policy criteria are met, and that these device codes are not medically necessary for Commercial Products due to insufficient evidence of net health benefit.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.